PNC Financial Services Group Inc. Cuts Stock Position in LivaNova PLC (NASDAQ:LIVN)

PNC Financial Services Group Inc. reduced its stake in LivaNova PLC (NASDAQ:LIVN) by 10.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,653 shares of the company’s stock after selling 303 shares during the period. PNC Financial Services Group Inc.’s holdings in LivaNova were worth $137,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in LivaNova by 6.0% during the 3rd quarter. Vanguard Group Inc. now owns 1,770,277 shares of the company’s stock worth $93,612,000 after acquiring an additional 100,133 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of LivaNova by 6.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,241,985 shares of the company’s stock valued at $64,262,000 after purchasing an additional 74,067 shares during the period. Greenlight Capital Inc. boosted its stake in shares of LivaNova by 3.5% in the fourth quarter. Greenlight Capital Inc. now owns 1,229,316 shares of the company’s stock valued at $63,605,000 after purchasing an additional 42,040 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of LivaNova by 96.1% in the third quarter. Ameriprise Financial Inc. now owns 916,632 shares of the company’s stock valued at $48,471,000 after purchasing an additional 449,136 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its holdings in LivaNova by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 829,576 shares of the company’s stock valued at $42,922,000 after purchasing an additional 14,675 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Daniel Jeffrey Moore sold 56,623 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $60.11, for a total transaction of $3,403,608.53. Following the completion of the transaction, the director now directly owns 27,534 shares in the company, valued at approximately $1,655,068.74. The sale was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Robert W. Baird increased their target price on LivaNova from $58.00 to $66.00 and gave the company a “neutral” rating in a research note on Thursday, May 2nd. Mizuho increased their price objective on shares of LivaNova from $75.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, May 2nd. StockNews.com upgraded shares of LivaNova from a “hold” rating to a “buy” rating in a research note on Thursday, April 25th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $72.00 price target on shares of LivaNova in a research note on Thursday, June 6th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $66.20.

LivaNova Stock Down 0.2 %

Shares of NASDAQ:LIVN opened at $52.79 on Friday. The company’s fifty day moving average is $57.83 and its two-hundred day moving average is $54.24. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.71 and a current ratio of 3.17. LivaNova PLC has a 1-year low of $42.75 and a 1-year high of $64.47. The stock has a market capitalization of $2.86 billion, a price-to-earnings ratio of -87.98 and a beta of 0.99.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.28. LivaNova had a negative net margin of 2.68% and a positive return on equity of 13.59%. The firm had revenue of $294.90 million for the quarter, compared to analyst estimates of $278.17 million. During the same quarter in the prior year, the business earned $0.43 earnings per share. LivaNova’s quarterly revenue was up 12.0% on a year-over-year basis. Equities analysts anticipate that LivaNova PLC will post 2.6 EPS for the current year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.